Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00675_DB00682_nanopub.RARoj_i7GRTxkkPTIQN8tzINbN1F8zrb-DXM3bU4gW1hA#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00675_DB00682 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00675_DB00682 label "DDI between Tamoxifen and Warfarin - Tamoxifen, a CYP2C9 inhibitor, may increase the serum concentration of warfarin by decreasing its metabolism. Concomitant therapy is contraindicated due to significant increase in bleed risk. [drugbank_resource:DB00675_DB00682]" assertion.
- drugbank_resource:DB00675_DB00682 identifier "drugbank_resource:DB00675_DB00682" assertion.
- drugbank_resource:DB00675_DB00682 title "DDI between Tamoxifen and Warfarin - Tamoxifen, a CYP2C9 inhibitor, may increase the serum concentration of warfarin by decreasing its metabolism. Concomitant therapy is contraindicated due to significant increase in bleed risk." assertion.
- drugbank:DB00682 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00675_DB00682 assertion.
- drugbank:DB00675 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00675_DB00682 assertion.